Genmab — August 2017
-
Pipelinen i fokus i Genmab-regnskab
Salgstallene for kerneproduktet Darzalex er allerede meldt ud, og derfor vil fokus i det kommende halvårsregsnskab fra Genmab være på nyheder om biotekselskabets pipelineprojekter - og ikke så meget på regnskabstallene.
(medwatch.dk)
-
-
true bibob- however that is also not all their choice; firstly they are restricted from selling just before the accounts and secondly when they excercise warrants they will need to pay for them and thus sell some if they dont want to use (or dont have) their own funds
-
yep, so just go back in history, check how many where awarded at what dates (and by the way some are 7yrs if I am correct) and then you only have to distract those that have been excercised or unvalid (eg employee leaves the firm) and you are there. Good luck, as I said before, I admit I am just too lazy
-
God morgen.
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind